业绩稳步攀升。2025 年3 月25 日,三生制药发布2024 年年度业绩公告,2024 年公司实现收入91.1 亿元,同比增长16.5%;实现毛利78.3 亿元,同比增长17.9%;实现归母净利润20.9 亿元,同比增长34.9%;实现扣非归母净利润23.2 亿元,同比增长18.8%。核心品种稳健增长。2024 年全年特比澳销售收入达到50.6 亿元,同比增长20.4%,2024 年4 月特比澳...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.